Showing posts with label older. Show all posts
Showing posts with label older. Show all posts

Wednesday, November 24, 2010

Healthy older brains have not significantly reduced over time according to new research.

young_girl_and_grandfather.jpgThe belief that healthy older brains is substantially smaller than younger brains not are possibly arising from studies, people which go undetected, slowly developing brain disease was, kill cells in key areas, according to new research.

As a result, previous findings can atrophy and normal size for the older brain underestimated by the report "the prevalence of cortical gray matter atrophy may be overestimated in healthy aging brain," appears in the issue September 2009 the American Psychological Association Journal of Neuropsychology have overestimated.

parts of the brainThe new brain study tested participants in Holland's long-term Maastricht aging study, who freely neurological problems such as dementia, Alzheimer's disease, Crohn's disease Parkinson's disease or stroke. Once participants were different from healthy, they took neuropsychological tests, including a screening test for dementia on the baseline and every three years for nine years.

The participants received in year 3, seven different parts of the brain MRI scans to measure areas and the frontal and cingulate areas of the cognitive critical cortex including memory-laden hippocampus, the areas around the hippocampus as e.g. Parahippocampal.Hippocampus plays an important role in the long-term and spatial navigation during field Parahippocampal, the hippocampus surrounds an important role in memory encoding and retrieval plays.

Dementia and Alzheimer's disease hippocampus is one of the first regions of the brain damage suffered; problems with memory and disorientation appear cingulate areas of cognitive critical cortex functions under the first Symptome.Die as an integral part of the limbic system that emotion formation and processing, learning, memory and respiratory control.

Study yields surprising results

After examining the behavioral data collected from 1994 to 2005 (with MRIs taken between 1997 and 1999 depending if people entered the study), the researchers participants divided into two groups: a group of 30 people showed significant cognitive decrease but were still dementia-free (average starting age 69.2 years) and a group of 35 cognitively healthy people stayed free of dementia (average starting age 69.1 years).

Cognitive decline was by drop of at least 30 per cent to two or more of the six core tests of the verbal learning and fluid, callback, processing speed, and complex information processing and/or drop of 3 or more points, fairs or scores of 24 or lower (raising suspicion for cognitive impairment) on the mini-mental state examination screening tool for dementia.

30 People cognitively over nine years showed a significant effect for ages in the hippocampus and Parahippocampal declined and in the frontal and cingulate Cortices while 35 cognitively healthy people nicht.Unter had the older participants the people whose understanding is deteriorating, smaller brain areas as younger Teilnehmer.Laut reflects the authors the apparent age atrophy in gray matter more likely pathological changes in the brain, the significant cognitive decline as aging itself behind.

The bottom line

As long as people remain healthy cognitive, the gray matter of areas could support of cognition don't ever verkleinert.Den according to researchers, should these findings scientists caution on conclusions of brain studies that use objective definitions and screen participants in the course of time.


View the original article here

Monday, November 22, 2010

Growth hormone stimulators help older adults

Substance which stimulates the secretion of growth hormone can help older adults improve their physical function and reduce your body fat percentage which will be presented at the International Congress of Neuroendocrinology in Pittsburgh, according to the study results. The results are by Dr. George Merriam, Professor of medicine at the University of Washington and a doctor with health care VA Puget Sound. Coordinate helped Merriam endocrine aspects of this multi-site study, together with Dr. Heidi white from Duke University and researcher at Pfizer, Inc. almost 400 adults from 65 to 84 years of age were enrolled in the study, and a placebo or one of the four different levels of an oral growth hormone secretagogue (GHS) which stimulates the secretion of human growth hormone were divided into groups receive. Researchers measured the participants fat and muscle mass (muscle) as your performance in the physical tests such as stair climbing and walking heel-to-toe. Participants were given the level of growth hormone and a composite IGF-1, a hormone that reacts to growth hormone and conveys some of the impact called blood tests. GHS treatment participants saw a significant increase in the non-fatty matter - 1.5 kg or 3.3 pounds. The GHS treatment led to improved physical function in the six - to 12 - month study period. The participants had higher growth hormone and IGF-1 in their Bloodstreams. Patients had the GHS treatment minor side effects, including increased fatigue, insomnia, and fasting blood sugar levels. Growth hormone is growth and production of the hormone crucial childhood Summit during puberty. However, it continues to affect physical function in our lifetime and regulates metabolism and body composition. As middle-aged adults move begins growth hormone production taper off. Many of the effects of aging - abdominal fat, reduced muscle mass and decreased physical function - look very similar as the symptoms of growth hormone deficiency in younger people. As this aging effects in set, many older adults find it difficult to care for yourself and you lose quality of life and often turn to long-term care. "If we had something that could reduce the drop off in physical function, we could improve the quality of life for older adults, and reduce the costs of long-term care, said Merriam.""What we want to do is take the steep curve of the physical function, that decrease with age, and shall keep a much flatter decrease or even a plateau, so more physical mobility and strength as instead people of deteriorating age." Researchers study the aging process believe that growth hormone and IGF-1 can be two of the most important connections to regulate, the effects of aging and that the stimulus could help production of hormones prevent these effects. Other studies have shown that treatment can increase the levels of growth hormone and IGF-1, and can help improve a patient's body composition. This study is the first to show not only the physical function stability, but improving. "This is a proof of concept that can help GHS with body composition and physical function," said Merriam. "Very encouraging results, and we should consider further whether GHS can help in the long term, some to mitigate the negative effects of aging." However, he added that many steps remain to determine whether this concept could be converted to an effective and safe treatment. The GHS was used in the study discovered and developed by Pfizer Global research and development, and is only available for research, not as a prescription or over-the-counter traded drug. This study researchers at Stanford University, the University of Arkansas, included the University of Washington and Duke University sites Johns Hopkins University and the Veterans Affairs healthcare system. The research was supported by Pfizer, Inc. Note: this research in a press conference Wednesday at 21, at the International Congress of Neuroendocrinology in Pittsburgh featured will. Reporter can also participate in the press conference via telephone conference. For more information about the session and visit press conference:
http://newsbureau.UPMC.com/ICN2006/

View the original article here